MPSYF News and Press, Morphosys Ag Ord From 01/22/21

ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. 2020 was a year of monumental progress in renewable energ...

The following slide deck was published by MorphoSys AG in conjunction with this event. For further details see: MorphoSys AG (MOR) Presents At 39th Annual J.P. Morgan Healthcare Conference - Slideshow

The following slide deck was published by MorphoSys AG in conjunction with this event. For further details see: MorphoSys AG (MOR) Investor Presentation - Slideshow

MorphoSys AG (MPSYF) Q3 2020 Earnings Call Transcript November 12, 2020 08:00 AM ET Company Participants Julia Neugebauer - Director, Investor Relations Jean-Paul Kress - Chief Executive Officer Roland Wandeler - Chief Operating Officer Malte Peters - Chief Research & Development Officer ...

MorphoSys AG (MOR) Q3 2020 Earnings Conference Call November 12, 2020, 08:00 AM ET Company Participants Julia Neugebauer - Director of IR Jean-Paul Kress - CEO Jens Holstein - CFO Malte Peters - Chief Research and Development Officer Roland Wandeler - COO Conference Call Participants Geoffrey...

The following slide deck was published by MorphoSys AG in conjunction with their 2020 Q3 earnings call. For further details see: MorphoSys AG 2020 Q3 - Results - Earnings Call Presentation

MorphoSys AG (MPSYF) announces that Jens Holstein steps down as the chief financial officer and board member, effective Dec. 31, 2020. Holstein says "...it is time for me to explore new opportunities.""Since joining in 2011, Jens' numerous contributions added substantially to making the ...

MorphoSys AG (MOR) Q2 2020 Earnings Conference Call August 06, 2020, 08:00 AM ET Company Participants Anja Pomrehn - Head of IR Jean-Paul Kress - CEO Jens Holstein - CFO Malte Peters - Chief Research and Development Officer Roland Wandeler - COO Conference Call Participant...

MorphoSys receives FDA approval for Monjuvi MorphoSys AG ( MOR ) announced that the FDA has approved the use of Monjuvi in conjunction with lenalidomide, for treating adult patients suffering from relapsed/refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified, includ...

MorphoSys AG (MPSYF) Q1 2020 Earnings Conference Call May 7, 2020 8:00 AM ET Company Participants Julia Neugebauer - Director of IR Jean Kress - Chairman of Management Board, MD & CEO Jens Holstein - CFO & Member of the Management Board Malte Peters - Chief Research &a...